
        <!DOCTYPE html>
        <html>
        <head>
            <title>MANNKIND CORPORATION (MNKD) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">MANNKIND CORPORATION (MNKD)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">15</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">11</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.46</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6a8ea6182101fd17dd4527c39cd1821600acbc7e0fa55921e4a1d538825e5404" target="_blank" rel="noopener noreferrer">MannKind's Plan of Increasing Revenue Base, Advancing Potential Pipeline Enhances its Value Creation, Oppenheimer Says</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-09-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">MannKind's (MNKD) game plan of enhancing its revenue base, while also advancing a potential pipeline...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=86d1c8eca862c0cc6250589e8b6e3435b747fb482e56141af7711315ee88843f" target="_blank" rel="noopener noreferrer">H.C. Wainwright Reiterates a Buy Rating on MannKind Corporation (MNKD)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.49
                                </span>
                            </div>
                            <div class="article-summary">MannKind Corporation (NASDAQ:MNKD) is one of the best long-term penny stocks to buy right now. On August 25, H.C. Wainwright reiterated a Buy rating on MannKind Corporation (NASDAQ:MNKD), setting a $9...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0e795b0005fb4ecbd2969d21cb908db0cb4653f0c69b3554032e013c006abe79" target="_blank" rel="noopener noreferrer">Why MannKind (MNKD) Is Up 11.7% After Expanding Technosphere Partnership With United Therapeutics</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.93
                                </span>
                            </div>
                            <div class="article-summary">On August 24, 2025, United Therapeutics announced an amendment to its license and collaboration agreement with MannKind, expanding the deal to cover a new development product formulated using MannKind...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=794153fd8ef07fc98c7e8226f55ae795772839d04e221b5ad95b71caf9bc3a79" target="_blank" rel="noopener noreferrer">MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.30
                                </span>
                            </div>
                            <div class="article-summary">We recently published 10 Best Biotech Stocks to Buy Under $10. MannKind Corporation stands fifth among them. MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company developing inhaled therap...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b7952d6c5c7e2959e8e3316ace1b6ed1d946ba54e4103af8bd9eb42de08cee64" target="_blank" rel="noopener noreferrer">Should the Expanded Technosphere Partnership With MannKind Shape United Therapeutics’ (UTHR) Investment Outlook?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">On August 24, 2025, MannKind Corporation announced an amendment to its global license and collaboration agreement with United Therapeutics, expanding the partnership to include an additional investiga...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ce54f17cd59d36ff86737a5c22faf76008fc0b20196a61f44f1a50ba9cf96dd0" target="_blank" rel="noopener noreferrer">Marvell downgraded, Dollar Tree upgraded: Wall Street's top analyst calls</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Marvell downgraded, Dollar Tree upgraded: Wall Street's top analyst calls...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=38ed1a80f4bd13fabebcbafda4157406e94de0b1a58722220e51d6a44cbcdec6" target="_blank" rel="noopener noreferrer">New Strong Sell Stocks for August 27th</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CVGI, INBK and MNKD have been added to the Zacks Rank #5 (Strong Sell) List on August 27, 2025....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=476481d51056d573b9b5e3a3597e062c0ae95924135904239c0d996e5923d471" target="_blank" rel="noopener noreferrer">MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.73
                                </span>
                            </div>
                            <div class="article-summary">Initial collaboration led to Tyvaso DPI®, the first FDA-approved dry powder inhalation treatment for pulmonary hypertensionDANBURY, Conn. and BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corpora...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=34ee1d105639c89725e99148b30afbee7e16dfad747b10f15cbd9ead0e63e8b0" target="_blank" rel="noopener noreferrer">MannKind to Present at Upcoming Investor Conferences</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled the...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1d5ae6eed302e3289e6f81c866194b491f6605b0f2f228f7607f8fd149bad9d9" target="_blank" rel="noopener noreferrer">Leerink Partners Reiterates a Buy Rating on MannKind Corporation (MNKD), Keeps the PT at $7</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-26</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">MannKind Corporation (NASDAQ:MNKD) is one of the top strong buy stocks under $5 to buy now. On August 8, Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on MannKind Corporation (NASDA...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f1746a6d7fc87959b2a8df9bdccf5f27e90d630e5e3561d1c52ab3649cbf7ce9" target="_blank" rel="noopener noreferrer">MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX®, an innovative treatment for edema due to chronic heart failure and chronic kidney disease, addressing signi...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=750dac81b74ec79b91b88fc059619364c70c82f5626ca640e253acd9a0a97e39" target="_blank" rel="noopener noreferrer">MannKind to Acquire scPharmaceuticals for Up to $360 Million</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-25</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.34
                                </span>
                            </div>
                            <div class="article-summary">MannKind (MNKD) said Monday it has agreed to acquire scPharmaceuticals (SCPH) for a total deal value...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c76adeb0d387ef5c7bf34076b29bd425b46a06cecb0d524a0debed11105a98f4" target="_blank" rel="noopener noreferrer">Leerink Partners Reiterates a Buy on MannKind Corporation (MNKD), Keeps the PT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.51
                                </span>
                            </div>
                            <div class="article-summary">MannKind Corporation (NASDAQ:MNKD) is one of the Most Oversold Penny Stocks to Buy Now. On August 6, Faisal Khurshid from Leerink Partners reiterated a Buy rating on MannKind Corporation (NASDAQ:MNKD)...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=548a93949d9358e4602bf37650ee4d251876c7b87087ab42c2c32c9f4b3f7049" target="_blank" rel="noopener noreferrer">MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">We recently published 12 Best Healthcare Stocks to Buy Under $30. MannKind Corporation (NASDAQ:MNKD) is one of the best healthcare stocks. MannKind Corporation (NASDAQ:MNKD)’s most recent milestone is...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=93240a21f77074826ed77d4ed31a01a202490b467f7e112279cdf94538b48de8" target="_blank" rel="noopener noreferrer">MannKind Second Quarter 2025 Earnings: EPS: US$0.002 (vs US$0.007 loss in 2Q 2024)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.38
                                </span>
                            </div>
                            <div class="article-summary">MannKind ( NASDAQ:MNKD ) Second Quarter 2025 Results Key Financial Results Revenue: US$76.5m (up 5.7% from 2Q 2024......</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        